These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3501622)

  • 21. Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton.
    Frontelo P; González-Garrigues M; Vilaró S; Gamallo C; Fabra A; Quintanilla M
    Exp Cell Res; 1998 Nov; 244(2):420-32. PubMed ID: 9806792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The cultivation features, growth characteristics and oncogenicity of "serum-free" populations of transformed fibroblasts].
    Pleskach VA; Kozhukharova IV; Artsybasheva IV; Goĭlo TA; Tarunina MV; Filatova NA
    Tsitologiia; 1994; 36(8):806-15. PubMed ID: 7701611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoplastic transformation by quartz in the BALB/3T3/A31-1-1 cell line and the effects of associated minerals.
    Saffiotti U; Ahmed N
    Teratog Carcinog Mutagen; 1995-1996; 15(6):339-56. PubMed ID: 8732883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
    Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
    Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
    Somers KD; Murphey MM
    Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage and lymphocyte-depleted thymus reticuloepithelial cell cultures: establishment and functional influence on T-lymphocyte maturation, C-type virus expression and lymphomatous transformation in vitro.
    Boniver J; Declève A; Dailey MO; Honsik C; Lieberman M; Kaplan HS
    Thymus; 1981 Feb; 2(4-5):193-213. PubMed ID: 6262953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of mouse T-cell lymphoma lines from different long-term interleukin 2-dependent cultures.
    Giglia JS; Ovak GM; Yoshida MA; Twist CJ; Jeffery AR; Pauly JL
    Cancer Res; 1985 Oct; 45(10):5027-34. PubMed ID: 3875403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promotion of fetal liver cell engraftment in irradiated mice by activated T lymphocytes.
    Plotnicky H; Touraine JL
    Bone Marrow Transplant; 1993 Oct; 12(4):307-14. PubMed ID: 8275029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K; Cornelius SC; Danielpour D
    Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic identification of early members of the T cell lineage.
    Berman JW; Basch RS
    J Immunol; 1982 Apr; 128(4):1718-22. PubMed ID: 6801121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of differentiation control in transformed 3T3 T proadipocytes.
    Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
    Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a mouse thymic epithelial cell line, IT-76MHC and a brief review on cultured thymic epithelial cells.
    Itoh T; Nakamura M; Yagi H; Soga H; Doi H; Koja S; Nanno M; Suzuki R; Satomi S; Kasahara S
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):1-18. PubMed ID: 11292244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro growth control phenotypes of transformed rodent cells prior to and following tumorigenesis.
    O'Neill FJ; Renzetti L
    Cancer Res; 1983 Feb; 43(2):521-8. PubMed ID: 6848175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
    Cheever MA; Greenberg PD; Irle C; Thompson JA; Urdal DL; Mochizuki DY; Henney CS; Gillis S
    J Immunol; 1984 May; 132(5):2259-65. PubMed ID: 6609193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro induction of malignant transformation and in vivo resistance to tumor growth in the X/Gf mouse.
    Nahas F; Lichtig C; Gershon H
    J Natl Cancer Inst; 1983 Jul; 71(1):217-21. PubMed ID: 6306324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.